American Academy of Environmental Medicine

AMERICAN ACADEMY OF ENVIRONMENTAL MEDICINE

Conference Presentation Form

Human Microbiome in Health and Disease

The American Academy of Environmental Medicine (AAEM) is seeking presentations for its upcoming annual meeting to be held at the Westin Hotel in Westminster, Colorado, October 4 – 7, 2018. Presentations should educate and enable practitioners to recognize the potential role of the human microbiome in various disease states, including allergy, autoimmunity, inflammatory bowel disease, obesity, and neuropsychiatric illnesses, among many other conditions, and implement evidence-based therapeutic interventions. Your presentation should integrate one of the stated objectives outlined below.

The purposes of this conference are to enable medical practitioners:

1) To understand the emerging science regarding the impact of the microbiome on health and disease

2) To apply Environmental/ Integrative Medicine principles to improve patient outcomes.

STATEMENT OF NEED:

Physicians must possess and maintain a wide-ranging knowledge base regarding a variety of topics covering all body systems as well as common and uncommon disorders. The American Academy of Environmental Medicine’s goal is to educate and enable practitioners to recognize the potential role of the human microbiome in various disease states.

Interest in the role of the microbiome in human health has exploded over the past ten years. An increasing number of studies propose that part of what determines how the human body functions may be not only our genes, but also the genes of the trillions of microbes that live on and in our bodies. Taken collectively, these organisms outnumber our own human cells 10 to 1, making up 5 pounds of our body weight (1). Studies are discovering that our bacteria (or lack of) can be associated with: obesity, malnutrition, heart disease, diabetes, celiac disease, eczema, asthma, multiple sclerosis, colitis, some cancers, autism and potentially in fatty liver disease (1).

With a growing awareness that many of our modern diseases are “lifestyle” related and that greater than 50% of current medications do not work for the individuals taking them, research in the microbiome presents a potential opportunity to provide substantial preventative treatments– with few or no adverse events.

Experts will discuss emerging evidence regarding the microbiome and potential contributions of the microbiota in human health and the diagnosis and treatment of disease.

FOCUS AREA:

The goal of this conference is to present current data regarding the interactions among the immune system, the microbiome, inflammation and the environment. This data should be evidence-based, including laboratory and clinical diagnosis and therapeutic reports.

This conference will acquaint health care professionals with validated alternative methods, so they can provide their patients better-informed advice. The presentations will improve front line-clinicians’ ability to recognize the role of the human microbiome in specific disease states. Practitioners will learn to employ Environmental/ Integrative Medicine methods to improve treatment for the diagnosis and treatment of disease.

Suggested Topics Include:

1 | Page

AMERICAN ACADEMY OF ENVIRONMENTAL MEDICINE

Genomics
Methylation
Endocrine Disruption
Toxic chemicals

Neurotoxicity
Immunology
Nutrition

1 | Page

AMERICAN ACADEMY OF ENVIRONMENTAL MEDICINE

The focus areas for this conference were developed by the Meeting Planning Committee and the Executive Committee of the AAEM based on feedback from participants in the AAEM 2016 Annual Meeting, data collected from clinicians who completed the AAEM Needs Assessment Survey, literature review and documentation of increased demand for environmental medicine education for health care professionals, as clearly demonstrated by the overwhelming success of the previous conferences.

TARGET AUDIENCE:

The target audience is physicians and other healthcare clinicians who wish to advance their current knowledge of interactions between humans and their microbiome and who wish to stay abreast of advances in medical research.

TIMELINE:
• Monday, September 25, 2017 -- Submission Deadline
• Monday, November 13, 2017 -- Selected session presenters notified
• Monday, August 13, 2018 -- Presentations must be reviewed and approved by the CME

Planning Committee (Email presentation to ). Changes may not be

made to content, presenters, or slides after review.

• October 5 - 7, 2018 -- Live presentations

BEFORE YOU BEGIN:

Authors should keep in mind that all presentations must be evidence- or clinical observation- based, show references/citations, and provide a balanced view of any protocols.

Each diagnostic or treatment presentation must provide “how-to” guidelines that attendees may take home and implement in their practices, unless special training is required – in which case, that information should be provided.

You will need to list three (3) session objectives in your proposal, so please have that information prepared prior to your submission. AAEM’s 2018 Annual Meeting objectives are listed below, and the information submitted in your proposal should address at least 1 of the objectives to help set the stage for AAEM’s 2018 Annual Meeting. Please ensure that your presentation is unique to AAEM’s conference; and is not given to another organization or event at least two (2) months before/after AAEM’s scheduled annual meeting dates (October 5 - 7, 2018).

Recognize the emerging science regarding the impact of the microbiome on health and disease
Explain how lifestyle choices change the nature of the microbiome and the metabolic significance of these changes
Discuss how leading edge novel techniques to restore a healthy microbiome may pave the way for meaningful treatment of autism, autoimmune conditions and inflammatory disorders

PREPARE YOUR INFORMATION BEFORE SUBMITTING:

All information received, especially your abstract and bio, should be proofed for spelling and grammatical errors. Your submission will be reviewed by AAEM’s Planning Committee UNALTERED (typographical errors will not be corrected)
AAEM reserves the right to edit titles and content of your abstract submission. You are required to:

Submit an abstract of your proposed presentation (not to exceed 250 words), including 2-3 references that provide the best evidence underlying your proposed talk.

Submit 3 specific learning objectives for the attendees (e.g., At the end of this presentation participants will be able to....)

Provide a brief biography for EACH Presenter (limited to 250 words written in paragraph format) to be posted on the conference website (do not compose in the first person or list hobbies and/or person family comments).

Provide a digital photo for use in promoting the conference

Abstract Submission Form

Name of Speaker: *As you would like it printed in all marketing material *Please indicate professional designations
Mailing Address:
Phone Number: / Mobile Number: / E-mail Address:
Proposed Session Title: *50 characters or less
Proposed Session Time Requested: *not to exceed 50 minutes
Presentation abstract: *not to exceed 250 words
Include 2-3 references that provide the best evidence underlying your proposed talk.
*Or e-mail and attach abstract to De Fox

Learning Objectives

Please indicate which of the following conference objective(s) your presentation addresses:
Apply a whole body approach to efficaciously diagnose the underlying factors of mental illness.
Integrate new diagnostic tools and environmental/integrative therapies to affect patients’ mental health outcomes.
Recognize the importance of the gut and hormone optimization in the treatment of mental health.
Incorporate into clinical practice non-pharmacological interventions to address patient’s mental health problems.
Please identify three learning objectives that the participants will be able to improve upon or achieve after attending your session.
Learning Objective 1:
This is a change in: / ☐ competence / ☐ performance / ☐ patient outcomes
Learning Objective 2:
This is a change in: / ☐ competence / ☐ performance / ☐ patient outcomes
Learning Objective 3:
This is a change in: / ☐ competence / ☐ performance / ☐ patient outcomes

Teaching Methods

Please indicate which of the following teaching methods you will be using:
☐Case Studies / ☐Didactic Lecture (with Q&A)
☐Lecture with Interactive Components / ☐Pro/Con Debate
☐Break-out Session (smaller groups) / ☐Medical Guideline Presentation
☐Meet the Professor (bring cases/questions from your practice)

We suggest that you utilize as many interactive processes as possible to stimulate and reinforce learning (i.e. case reports, ancillary tools, patient compliance handouts, office staff management tools, algorithms.)

ACGME and IOM Competencies

Please indicate which of the competencies below that you will address in your presentation.
ACGME/ABMS Competencies
☐Patient care that is compassionate, appropriate, and effective for the treatment of health problems and the promotion of health / ☐Interpersonal and communicationskills that result in effective information exchange and teaming with patients, their families, and other health professions
☐Medical knowledge about established and evolving biomedical, clinical, and cognate (e.g. epidemiological and social-behavior) sciences and the application of this knowledge to patient care / ☐Professionalism as manifested through a commitment to carrying out professional responsibilities, adherence to ethical principles, and sensitivity to a diverse patient population
☐Practice-based learning and improvement that involves investigation and evaluation of their patient care, appraisal and assimilation of scientific evidence, and improvements in patient care. / ☐System-based practice, as manifested by actions that demonstrate an awareness of and responsiveness to the larger context and system for health care and the ability to effectively call on system resources to provide care that is of optimal value.

Institute of Medicine Core Competencies

IOM Core Competencies
☐Provide patient-centered care
Identify, respect, and care about patients’ differences, values, preferences, and expressed needs; relieve pain and suffering; coordinate continuous care; listen to, clearly inform, communicate with, and educate patients; share decision making and management; and continuously advocate disease prevention, wellness, and promotion of healthy lifestyles, including a focus on population health. / ☐Apply quality improvement
Identify errors and hazards in care; understand and implement basic safety design principles, such as standardization and simplification; continually understand and measure quality of care in terms of structure, process, and outcomes in relation to patient and community needs; and design and test interventions to change processes and system of care, with the objective of improving quality.
☐Work in interdisciplinary teams
Cooperate, collaborate, communicate, and integrate care in teams to ensure that care is continuous and reliable. / ☐Utilize informatics
Communication, manage, knowledge, mitigate error and support decision making using information technology.
☐Employ evidence-based practice
Integrate best research with clinical expertise and patient values for optimum care, and participate in learning and research activities to the extent feasible.

Biography

Biography: To be used in promotional materials *not exceed 250 words
*Or e-mail and attach biography to De Fox
Digital Photo
Please make sure to email and attach a Digital Photo to De Foxregardless of how you submit your presentation form.

Disclosure

Have you (or your spouse/partner) had a personal financial relationship in the last 12 months with a commercial interest that produces health care goods or services consumed by, or used on patients that will be presented in this CME activity or in your presentation?
☐No
*Skip to declaration section below / ☐Yes
*Please list your disclosures below
Type of Personal Financial Relationship / Name of Commercial Interest Whose Products or Services will be Addressed
Consultant
Speaker’s Bureau
Grant/Research Support (principal investigator or working directly for company/company’s agent)
Stock Shareholder (self-managed)
Other (e.g., royalty, employee)
Please describe:
My presentation will include a discussion of “off-label” uses of a commercial product or an investigational use of a drug or device not yet approved. I will not use trade names of drugs.
☐Yes / ☐No / ☐Not Applicable
Please explain below:
☐This method does not require FDA-approval
☐“Off-label” use of pharmaceutical product
☐Other

1 | Page